Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

  • Joel R. Rosh*
  • , Dan Turner
  • , Anne Griffiths
  • , Stanley A. Cohen
  • , Douglas Jacobstein
  • , Omoniyi J. Adedokun
  • , Lakshmi Padgett
  • , Natalie A. Terry
  • , Christopher O'Brien
  • , Jeffrey S. Hyams
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science